Literature DB >> 12888134

Effect of acute hyperglycemia on the ischemic preconditioning effect of prodromal angina pectoris in patients with a first anterior wall acute myocardial infarction.

Masaharu Ishihara1, Ichiro Inoue, Takuji Kawagoe, Yuji Shimatani, Satoshi Kurisu, Kenji Nishioka, Takashi Umemura, Shuji Nakamura, Masashi Yoshida.   

Abstract

Acute hyperglycemia abolishes the ischemic preconditioning effect of prodromal angina pectoris in patients with acute myocardial infarction. We investigated a potential explanation for the association between acute hyperglycemia and adverse outcomes after acute myocardial infarction.

Entities:  

Mesh：

Year:  2003        PMID： 12888134     DOI： 10.1016/s0002-9149(03)00627-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  12 in total

Review 1.  Hyperglycemia in nondiabetic patients presenting with acute myocardial infarction.

Authors:  Binita Shah; Nicholas S Amoroso; Steven P Sedlis
Journal:  Am J Med Sci       Date:  2012-04       Impact factor: 2.378

2.  Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI.

Authors:  Christoph J Jensen; Holger C Eberle; Kai Nassenstein; Thomas Schlosser; Mani Farazandeh; Christoph K Naber; Georg V Sabin; Oliver Bruder
Journal:  Clin Res Cardiol       Date:  2011-02-24       Impact factor: 5.460

3.  Remote ischemic preconditioning fails to reduce infarct size in the Zucker fatty rat model of type-2 diabetes: role of defective humoral communication.

Authors:  Joseph Wider; Vishnu V R Undyala; Peter Whittaker; James Woods; Xuequn Chen; Karin Przyklenk
Journal:  Basic Res Cardiol       Date:  2018-03-09       Impact factor: 17.165

4.  Cardiac-specific overexpression of GTP cyclohydrolase 1 restores ischaemic preconditioning during hyperglycaemia.

Authors:  Zhi-Dong Ge; Irina A Ionova; Nikolina Vladic; Danijel Pravdic; Naoyuki Hirata; Jeannette Vásquez-Vivar; Phillip F Pratt; David C Warltier; Galen M Pieper; Judy R Kersten
Journal:  Cardiovasc Res       Date:  2011-03-21       Impact factor: 10.787

5.  Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning.

Authors:  Nikolina Vladic; Zhi-Dong Ge; Thorsten Leucker; Anna K Brzezinska; Jian-Hai Du; Yang Shi; David C Warltier; Phillip F Pratt; Judy R Kersten
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-09       Impact factor: 4.733

6.  Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society.

Authors:  Eiichi Araki; Atsushi Tanaka; Nobuya Inagaki; Hiroshi Ito; Kohjiro Ueki; Toyoaki Murohara; Kenjiro Imai; Masataka Sata; Takehiro Sugiyama; Hideki Ishii; Shunsuke Yamane; Takashi Kadowaki; Issei Komuro; Koichi Node
Journal:  Diabetol Int       Date:  2020-11-30

7.  Impact of Admission Glucose on Non-Diabetic Patients with ST-Segment Elevation Myocardial Infarction Treated with Percutaneous Coronary Intervention: A Meta-Analysis.

Authors:  Zhen-Xuan Hao; Yang Liu; Dan-Li Wang; Wen-Jie Han; Lei Wu; Heng-Liang Liu
Journal:  Acta Cardiol Sin       Date:  2016-03       Impact factor: 2.672

Review 8.  Preconditioning in humans.

Authors:  Shereif H Rezkalla; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

9.  Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study.

Authors:  Richard Engbersen; Niels P Riksen; Marc J Mol; Bert Bravenboer; Otto C Boerman; Patrick Meijer; Wim J G Oyen; Cees Tack; Gerard A Rongen; Paul Smits
Journal:  Cardiovasc Diabetol       Date:  2012-10-10       Impact factor: 9.951

10.  Admission glucose and risk of early death in non-diabetic patients with ST-segment elevation myocardial infarction: a meta-analysis.

Authors:  Cheng-jin Zhao; Zhen-xuan Hao; Rong Liu; Yang Liu
Journal:  Med Sci Monit       Date:  2015-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.